AzTrials
AzTrials

COPDNCT05972239

Balance Training in Chronic Obstructive Pulmonary Disease

A study testing Standard pulmonary rehabilitation program and Balance training added on standard pulmonary rehabilitation in people with COPD, run by Istituti Clinici Scientifici Maugeri SpA at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study will be to verify whether the addition of an exercise program aimed to improve balance can reduce the risk of falling in subjects with COPD over 80 years of age compared to the standard rehabilitation program. Patients will be randomly assigned in two groups (intervention and control). Read more about this study

Who is it for?
Ages 80 years and older
Conditions the study is for
COPD
What is being tested?
Standard pulmonary rehabilitation program and Balance training added on standard pulmonary rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteItaly
Study dates
1 May 2023to 19 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 80 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Age ≥ 80 years old,
  • Diagnosis of COPD according to GOLD Guidelines (Tiffenau Index <70%) under optimized medical treatment,
  • Able to perform and complete study procedures.

Who cannot join

  • Anticholinergic Cognitive Burden score ≥3,
  • Mini-Mental State Examination <22,
  • Acute or chronic impairment and/or medical diseases that are likely to preclude exercise testing and PR.
  • Brain lesions,
  • Inner ear disease
  • Visual deficit,
  • Lower limb surgery in the previous 6 months.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Department of pulmonary rehabilitation

    Tradate, Varese, 21049

Other trials in Italy

About this study

Official title: Balance Training: Its Effect on Pulmonary Rehabilitation of Elderly Subjects With Chronic Obstructive Pulmonary Disease

The aim of the study will be to verify whether the addition of an exercise program aimed to improve balance can reduce the risk of falling in subjects with COPD over 80 years of age compared to the standard rehabilitation program. Patients will be randomly assigned in two groups (intervention and control). The pulmonary rehabilitation (PR) program is organized in accordance with current guidelines.

Read the detailed description

Chronic Obstructive Pulmonary Disease-COPD is the most prevalent pathology among chronic airway diseases. The average age of life has increased. Subjects over 80 years old have peculiar characteristics. Individuals with COPD have an increased risk of falling compared with healthy peers. A pulmonary rehabilitation program reduces the risk of falling as measured by gait speed. Balance training on the elderly has been shown to be effective in improving muscle strength, coordination, balance and in reducing the risk and number of falls and the fear of falling.

The enrolled subjects will complete an in-patient PR program according to enrollment.

Control: education, aerobic and strength training and callisthenic exercises. Intervention: education, aerobic and strength training as group Control and balance training. At baseline will be recorded: demographics and anthropometrics, comorbidities, drug therapy, flow/volume curve, arterial blood gases, serum hemoglobin, history of fall, exacerbations and risk of sarcopenia. Before and after the PR the following outcome measures will be assessed: balance performance, peripheral muscle strength, gait speed, health status, dyspnea, quality of life, exercise capacity, confidence with balance and perceived change. Sample size calculation was performed based on the primary endpoint of the study. We estimate a number of 50 subjects.

Conditions
COPD
Being tested
Standard pulmonary rehabilitation program, Balance training added on standard pulmonary rehabilitation
Keywords
Exercise, Rehabilitation, Aged, postural balance
Medical subject headings
Pulmonary Disease, Chronic Obstructive, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard pulmonary rehabilitation programOther

    Educational interventions, 3 individual sessions of 10-20 minutes and 1 weekly group meeting of 45-60 minutes on nutrition and on the emotional management of the disease. Supervised and incremental aerobic training, lasting at least 30 minutes, 5/6 days a week for a total of 12-14 sessions. The initial workload will be set between 50-70% of the maximum load (watts) determined starting from the 6MWT using the Hill equation and will be increased to reach a perception of moderate-intense fatigue and/or dyspnea. Supervised strength training of the lower limbs and upper limbs, lasting 30 minutes, 5/6 times a week for a total of 12-14 sessions. The workload will be calibrated to allow the execution of 12 consecutive repetitions and will be progressively increased by 0.5 kg in order to cause a moderate/intense fatigue and/or dyspnea. Group exercises aimed at improving flexibility of the trunk, lower and upper limbs, lasting at least 30 minutes, 5/6 days a week, for a total of 12-14 sessions.

  • Balance training added on standard pulmonary rehabilitationOther

    Educational interventions, 3 individual sessions of 10-20 minutes and 1 weekly group meeting of 45-60 minutes on nutrition and on the emotional management of the disease. Supervised and incremental aerobic training, lasting at least 30 minutes, 5/6 days a week for a total of 12-14 sessions. The initial workload will be set between 50-70% of the maximum load determined from the 6MWT (Hill equation) and will be increased based on dyspnea. Supervised strength training of the lower limbs and upper limbs, lasting 30 minutes, 5/6 times a week for a total of 12-14 sessions. The workload will be progressively increased. Supervised balance training sessions lasting 30 minutes, 5/6 times a week for a total of 12-14 sessions. The sequence of the exercises will be personalized according to the result of the Berg Balance Scale and modified according to the progress.

Study groups in NCT05972239
Study groupRoleWhat they receive
ControlActive comparatorEducational interventions, aerobic and strenght training, flexibility exercises.
Receives: Other: Standard pulmonary rehabilitation program
InterventionExperimentalEducational interventions, aerobic and strenght training, balance training.
Receives: Other: Balance training added on standard pulmonary rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Balance

    Berg Balance Scale (BBS). Scores range from 0 (worst) - 4 (best).

    Measured: 3 weeks

Secondary outcomes (9)
  1. Peripheral muscle strenght

    Five sit to stand test (5STS). Time < 14.9 seconds (best), >14.8 seconds (worst).

    Measured: 3 weeks

  2. Gait speed

    4-meter gait speed test (4MGS). Time < 4.83 seconds (best), >4.82 seconds (worst).

    Measured: 3 weeks

  3. Health status

    The COPD Assessment Test (CAT) score ranges from 0 (best) to 40 (worst).

    Measured: 3 weeks

  4. Dyspnea

    Medical Research Council (mMRC) score ranges from 0 (best) to 4 (worst).

    Measured: 3 weeks

  5. Dyspnea on daily life activities

    Barthel Dyspnea Index (BDI) total score ranges from 0 (best) to 100 (worst).

    Measured: 3 weeks

  6. COPD Quality of life

    EuroQoL-5D total score ranges from 0 (worst) to 100 (best).

    Measured: 3 weeks

  7. Exercise capacity

    Six-Minute Walking Test (6MWT) measures the maximum walked distance in meters (m) in a given time (6 minutes).

    Measured: 3 weeks

  8. Confidence with balance

    Activities-specific Balance Confidence short form (ABC-6) Scale. Score from 0 (worst) to 100 (best).

    Measured: 3 weeks

  9. Perceived change

    Global perceived effect (GPE) scale. Score range from 1 (best) to 7 (worst).

    Measured: 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2023
  2. Study start1 May 2023
  3. Primary completion15 Jan 2025
  4. Study completion19 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05972239
Sponsor's protocol ID
2763
Status last verified
Apr 2026
First submitted
23 May 2023
Last updated
17 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Standard pulmonary rehabilitation program and Balance training added on standard pulmonary rehabilitation in people with COPD, run by Istituti Clinici Scientifici Maugeri SpA at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Balance (time frame: 3 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in